TOP > 外国特許検索 > CYCLIC PEPTIDE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME

CYCLIC PEPTIDE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME 新技術説明会

外国特許コード F130007592
整理番号 KG0098-WO01
掲載日 2013年8月5日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2012JP062513
国際公開番号 WO 2012/157674
国際出願日 平成24年5月16日(2012.5.16)
国際公開日 平成24年11月22日(2012.11.22)
優先権データ
  • 特願2011-110828 (2011.5.17) JP
発明の名称 (英語) CYCLIC PEPTIDE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME 新技術説明会
発明の概要(英語)

Provided are: a cyclic peptide compound which is capable of suppressing parakeratosis of the skin or a pharmacologically acceptable salt of the cyclic peptide compound

and a method for producing the cyclic peptide compound or a pharmacologically acceptable salt of the cyclic peptide compound. The present invention is a cyclic peptide compound which is represented by formula (I) (SEQ ID NO: 1) or a pharmacologically acceptable salt of the cyclic peptide compound. (In the formula, Xaa1 represents an optionally substituted alanyl group or glycyl group

Xaa2 represents an optionally substituted isoleucyl group or leucyl group

Xaa3 represents an optionally substituted glutamyl group or aspartyl group

Xaa4 represents an optionally substituted prolyl group or glycyl group

Xaa5 represents an optionally substituted glutaminyl group or asparaginyl group

Xaa6 represents an optionally substituted lysyl group or arginyl group

R1 represents a group represented by formula (II) (wherein n represents an integer of 1-10)

m represents an integer of 0 or 1

R2 represents a cystine residue

and l represents an integer of 0 or 1. In this connection, m and l are not 0 at the same time.)

  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • KWANSEI GAKUIN EDUCATIONAL FOUNDATION,
  • KNC LABORATORIES CO., LTD,
  • KADONO, NANAKO,
  • NAKAJIMA, KIICHIRO,
  • HIRAI, YOHEI
  • 発明者(英語)
  • KADONO, NANAKO,
  • NAKAJIMA, KIICHIRO,
  • HIRAI, YOHEI
国際特許分類(IPC)
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記「問合せ先」までお問い合わせください。

PAGE TOP

close
close
close
close
close
close